Biomerica (BMRA) Net Income (QoQ) (2011 - 2026)
Biomerica (BMRA) Net Income (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.82 Bn | 176.53 Bn | 6.27 Bn |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.59 Bn | 67.14 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.11 Bn | 25.82 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.32 Bn | - |
| 9 | Koninklijke Philips | 24.28 Bn | 21.15 Bn | 2.07 Bn |
| 10 | Biomerica | 4.97 Mn | 3.63 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 0.61% |
| Nov 30, 2025 | -66,100.00% |
| Aug 31, 2025 | 100.13% |
| May 31, 2025 | -32.59% |
| Feb 28, 2025 | -22.42% |
| Nov 30, 2024 | 27.81% |
| Aug 31, 2024 | -6.90% |
| May 31, 2024 | 35.82% |
| Feb 29, 2024 | -27.27% |
| Nov 30, 2023 | -33.13% |
| Aug 31, 2023 | 51.29% |
| May 31, 2023 | -40.85% |
| Feb 28, 2023 | -1.48% |
| Nov 30, 2022 | 21.53% |
| Aug 31, 2022 | -17.80% |
| May 31, 2022 | -1,588.60% |
| Feb 28, 2022 | 90.74% |
| Nov 30, 2021 | 27.05% |
| Aug 31, 2021 | 52.67% |
| May 31, 2021 | -53.41% |